Top Markets
#1 Pleasing Gold Pleasing Gold +562.02%
#2 Islamic Coin Islamic Coin +154.23%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +49.57%
#5 DogBull DogBull +38.73%
#6 Nockchain Nockchain +25.73%
#7 ORDI ORDI +21.49%
#8 PondCoin PondCoin +21.01%
#9 rsERG rsERG +18.16%
#10 Monad Monad +17.83%
Coin of the day
Pleasing Gold Pleasing Gold
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Kedudukan dalam Saham #27062
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Harga Saham
$2.04
Disegerakkan terakhir: 2025-12-09
Modal Pasaran
$35.38M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-2.39%
Negara
IE
Perdagangan Mural Oncology plc (MURA)

Kategori

Healthcare
Nisbah P/S bagi Mural Oncology plc (MURA)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Mural Oncology plc, nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk Mural Oncology plc dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH